식물 유래 보충제 시장 규모, 점유율, 성장, 세계 업계 분석, 지역별 동향 및 예측(2026-2034년)

Growth Factors of botanical supplements Market

The global botanical supplements market was valued at USD 60.02 billion in 2025 and is projected to grow from USD 66.20 billion in 2026 to USD 143.44 billion by 2034, registering a CAGR of 10.15% during the forecast period (2026-2034). Asia Pacific dominated the global market with a 31.34% market share in 2025, driven by rising health awareness, increasing disposable incomes, and growing demand for plant-based nutritional products.

Botanical supplements are dietary products formulated using herbs, spices, flowers, leaves, and other plant-derived ingredients to support overall wellness, immunity, weight management, bone health, digestive health, and cardiovascular health. Consumers are increasingly shifting toward natural healthcare solutions due to concerns over synthetic ingredients and the growing preference for preventive healthcare. Continuous product innovation, increasing availability through retail and e-commerce channels, and growing investments in botanical ingredient research are supporting long-term market expansion.

Market Drivers

The rising awareness regarding preventive healthcare and balanced nutrition is one of the major factors driving the botanical supplements market. Consumers across developed and emerging economies are increasingly adopting botanical supplements to improve immunity, reduce stress, support joint health, manage weight, and maintain overall wellness. Government health campaigns and increasing education regarding nutritional deficiencies are encouraging consumers to invest in plant-based dietary supplements.

Another important growth driver is the shift from pharmaceutical products toward botanical and herbal alternatives. Consumers increasingly believe that botanical supplements provide long-term health benefits with fewer side effects than synthetic products. Companies are responding by introducing organic, clean-label, and scientifically validated botanical formulations. In March 2023, Novella introduced a technology platform to produce high-value botanical micronutrients, helping improve global access to nutraceutical ingredients.

Market Restraints

Despite strong demand, the market faces several challenges. Botanical supplements often contain complex mixtures of active compounds whose effectiveness varies depending on plant species, cultivation conditions, harvesting methods, and extraction technologies. Maintaining consistent product quality remains difficult.

In addition, the availability of synthetic alternatives and chemically formulated supplements continues to create competition. Limited standardization, inconsistent clinical evidence, and regulatory complexities regarding botanical ingredient validation may also restrict wider market adoption.

Market Opportunities

Innovation in botanical ingredient extraction and formulation technologies is creating significant opportunities for manufacturers. Consumers increasingly seek products containing natural antioxidants, flavonoids, polyphenols, and phytonutrients supported by scientific research.

Growing demand for clean-label, vegan, non-GMO, and organic supplements is encouraging companies to develop premium botanical formulations. Expansion of online retail channels and increasing product availability across pharmacies and supermarkets are expected to further accelerate market growth during the forecast period.

Market Trends

One of the major trends influencing the botanical supplements market is the increasing use of premium botanical ingredients in functional nutrition products. Consumers are actively seeking products containing ashwagandha, curcumin, green tea, bacopa, boswellia, and other plant extracts known for their health benefits.

Manufacturers are investing heavily in research and development to validate ingredient efficacy while introducing innovative flavors, convenient dosage formats, and sustainable packaging. The growing popularity of personalized nutrition and preventive healthcare continues to strengthen demand for botanical supplements worldwide.

Segment Analysis

Based on form, tablets remain the leading segment due to their affordability, convenient dosage, long shelf life, and ease of transportation. Capsules, powders, liquids, and other delivery formats continue gaining popularity among consumers seeking personalized supplementation.

By source, the spices segment dominates the market owing to rising utilization of botanical extracts such as turmeric, ginger, ashwagandha, green tea, and curcumin across dietary supplements, nutraceuticals, cosmetics, and functional foods.

Based on functionality, the energy & weight management segment holds the largest market share due to increasing obesity concerns, rising fitness awareness, and growing demand for sports nutrition products. Bone & joint health, immunity, gastrointestinal health, anti-cancer formulations, and general wellness supplements continue to witness healthy demand.

By distribution channel, pharmacies and drug stores account for the largest market share with nearly 40% in 2025, supported by consumer trust, medical recommendations, and convenient product accessibility. Online retail continues to expand rapidly as consumers increasingly purchase health supplements through digital platforms.

Regional Analysis

Asia Pacific remained the largest regional market with a valuation of USD 18.81 billion in 2025 and is expected to reach USD 20.90 billion in 2026. Strong consumer awareness, expanding middle-class populations, and increasing product penetration across China, India, Japan, and Southeast Asia continue to support regional growth. China, Japan, and India remain key contributors to market expansion.

North America accounted for USD 18.18 billion in 2025 and is projected to reach USD 19.91 billion in 2026, supported by rising obesity rates, increasing preventive healthcare spending, and growing consumer preference for natural nutritional products.

Europe generated USD 14.15 billion in 2025 and is expected to reach USD 15.65 billion in 2026. Continued investments in nutritional research, innovation in botanical ingredients, and support from organizations promoting healthy nutrition are strengthening regional demand.

The Middle East & Africa market reached USD 2.93 billion in 2025 and is projected to grow to USD 3.20 billion in 2026, driven by rising health awareness and expanding availability of botanical dietary supplements.

Competitive Landscape

The global botanical supplements market remains moderately consolidated with leading companies focusing on capacity expansion, acquisitions, product innovation, and premium botanical formulations. Major industry participants include Dabur India, NBTY Inc., BASF SE, Ricola AG, Procter and Gamble, Nutraceutical International Company, The Himalaya Drug Company, Glanbia Nutritionals, Botanicalife International of America, Inc., and Proganiq.

Recent industry developments include Groupe Berkem launching its Biombalance gut health ingredient range in 2023, Kerry acquiring Natreon to strengthen its botanical ingredient portfolio, and Lemme introducing a new range of vegan botanical supplements in the U.S. market.

Conclusion

The global botanical supplements market is expected to witness strong growth through 2034, supported by rising health consciousness, increasing demand for plant-based nutrition, expanding preventive healthcare adoption, and continuous innovation in botanical ingredients. Growing consumer preference for clean-label, natural, and scientifically validated supplements, combined with expanding distribution channels and increasing investments in nutraceutical research, will continue driving long-term market expansion. With strong growth across Asia Pacific, North America, and Europe, botanical supplements are expected to remain a key segment within the global dietary supplements industry.

Segmentation By Source

• Spices
• Herbs
• Flowers
• Leaves
• Others

By Form

• Powder
• Liquid
• Tablets
• Capsules
• Others

By Functionality

• Energy & Weight Management
• General Health
• Bone & Joint Health
• Gastrointestinal Health
• Immunity
• Anti-cancer
• Others

By Distribution Channel

• Supermarkets/Hypermarkets
• Pharmacies/Drug Stores
• Online Retail
• Others

By Geography

• North America (By Source, Form, Functionality, Distribution Channel, and By Country)
  • U.S. (By Distribution Channel)
  • Canada (By Distribution Channel)
  • Mexico (By Distribution Channel)
• Europe (By Source, Form, Functionality, Distribution Channel, and By Country)
  • Germany (By Distribution Channel)
  • U.K. (By Distribution Channel)
  • Russia (By Distribution Channel)
  • France (By Distribution Channel)
  • Italy (By Distribution Channel)
  • Rest of Europe (By Distribution Channel)
• Asia Pacific (By Source, Form, Functionality, Distribution Channel, and By Country)
  • China (By Distribution Channel)
  • India (By Distribution Channel)
  • Australia (By Distribution Channel)
  • Japan (By Distribution Channel)
  • Rest of Asia Pacific (By Distribution Channel)
• South America (By Source, Form, Functionality, Distribution Channel, and By Country)
  • Brazil (By Distribution Channel)
  • Argentina (By Distribution Channel)
  • Rest of South America (By Distribution Channel)
• Middle East and Africa (By Source, Form, Functionality, Distribution Channel, and By Country)
  • South Africa (By Distribution Channel)
  • UAE (By Distribution Channel)
  • Rest of ME&A (By Distribution Channel)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Emerging Trends

4. Key Insights

• 4.1. Overview of the Parent/Related Markets
• 4.2. Industry SWOT Analysis
• 4.3. Supply Chain and Regulatory Analysis
• 4.4. Recent Industry Developments - Policies, Partnerships, New Product Launches, and Mergers & Acquisitions
• 4.5. Qualitative Analysis Related to COVID-19
  • 4.5.1. Impact of COVID-19 on the Market
  • 4.5.2. Supply Chain Challenges amidst Pandemic
  • 4.5.3. Potential Opportunities due to this Global Crisis

5. Global Botanical Supplements Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Size Estimates and Forecast
  • 5.2.1. By Source
    • 5.2.1.1. Spices
    • 5.2.1.2. Herbs
    • 5.2.1.3. Flowers
    • 5.2.1.4. Leaves
    • 5.2.1.5. Others
  • 5.2.2. By Form
    • 5.2.2.1. Powder
    • 5.2.2.2. Liquid
    • 5.2.2.3. Tablet
    • 5.2.2.4. Capsules
    • 5.2.2.5. Others
  • 5.2.3. By Functionality
    • 5.2.3.1. Energy & Weight Management
    • 5.2.3.2. General Health
    • 5.2.3.3. Bone & Joint Health
    • 5.2.3.4. Gastrointestinal Health
    • 5.2.3.5. Immunity
    • 5.2.3.6. Anti-Cancer
    • 5.2.3.7. Others
  • 5.2.4. By Distribution Channel
    • 5.2.4.1. Supermarkets and Hypermarkets
    • 5.2.4.2. Pharmacies
    • 5.2.4.3. Online Retail
    • 5.2.4.4. Others
  • 5.2.5. By Region
    • 5.2.5.1. North America
    • 5.2.5.2. Europe
    • 5.2.5.3. Asia Pacific
    • 5.2.5.4. South America
    • 5.2.5.5. Middle East & Africa

6. North America Botanical Supplements Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Size Estimates and Forecast
  • 6.2.1. By Source
    • 6.2.1.1. Spices
    • 6.2.1.2. Herbs
    • 6.2.1.3. Flowers
    • 6.2.1.4. Leaves
    • 6.2.1.5. Others
  • 6.2.2. By Form
    • 6.2.2.1. Powder
    • 6.2.2.2. Liquid
    • 6.2.2.3. Tablet
    • 6.2.2.4. Capsules
    • 6.2.2.5. Others
  • 6.2.3. By Functionality
    • 6.2.3.1. Energy & Weight Management
    • 6.2.3.2. General Health
    • 6.2.3.3. Bone & Joint Health
    • 6.2.3.4. Gastrointestinal Health
    • 6.2.3.5. Immunity
    • 6.2.3.6. Anti-Cancer
    • 6.2.3.7. Others
  • 6.2.4. By Distribution Channel
    • 6.2.4.1. Supermarkets and Hypermarkets
    • 6.2.4.2. Pharmacies
    • 6.2.4.3. Online Retail
    • 6.2.4.4. Others
  • 6.2.5. By Country (Value)
    • 6.2.5.1. U.S.
      • 6.2.5.1.1. By Distribution Channel
        • 6.2.5.1.1.1. Supermarkets and Hypermarkets
        • 6.2.5.1.1.2. Pharmacies
        • 6.2.5.1.1.3. Online Retail
        • 6.2.5.1.1.4. Others
    • 6.2.5.2. Canada
      • 6.2.5.2.1. By Distribution Channel
        • 6.2.5.2.1.1. Supermarkets and Hypermarkets
        • 6.2.5.2.1.2. Pharmacies
        • 6.2.5.2.1.3. Online Retail
        • 6.2.5.2.1.4. Others
    • 6.2.5.3. Mexico
      • 6.2.5.3.1. By Distribution Channel
        • 6.2.5.3.1.1. Supermarkets and Hypermarkets
        • 6.2.5.3.1.2. Pharmacies
        • 6.2.5.3.1.3. Online Retail
        • 6.2.5.3.1.4. Others

7. Europe Botanical Supplements Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Size Estimates and Forecast
  • 7.2.1. By Source
    • 7.2.1.1. Spices
    • 7.2.1.2. Herbs
    • 7.2.1.3. Flowers
    • 7.2.1.4. Leaves
    • 7.2.1.5. Others
  • 7.2.2. By Form
    • 7.2.2.1. Powder
    • 7.2.2.2. Liquid
    • 7.2.2.3. Tablets
    • 7.2.2.4. Capsules
    • 7.2.2.5. Others
  • 7.2.3. By Functionality
    • 7.2.3.1. Energy & Weight Management
    • 7.2.3.2. General Health
    • 7.2.3.3. Bone & Joint Health
    • 7.2.3.4. Gastrointestinal Health
    • 7.2.3.5. Immunity
    • 7.2.3.6. Anti-Cancer
    • 7.2.3.7. Others
  • 7.2.4. By Distribution Channel
    • 7.2.4.1. Supermarkets and Hypermarkets
    • 7.2.4.2. Pharmacies
    • 7.2.4.3. Online Retail
    • 7.2.4.4. Others
  • 7.2.5. By Country (Value)
    • 7.2.5.1. Germany
      • 7.2.5.1.1. By Distribution Channel
        • 7.2.5.1.1.1. Supermarkets and Hypermarkets
        • 7.2.5.1.1.2. Pharmacies
        • 7.2.5.1.1.3. Online Retail
        • 7.2.5.1.1.4. Others
    • 7.2.5.2. France
      • 7.2.5.2.1. By Distribution Channel
        • 7.2.5.2.1.1. Supermarkets and Hypermarkets
        • 7.2.5.2.1.2. Pharmacies
        • 7.2.5.2.1.3. Online Retail
        • 7.2.5.2.1.4. Others
    • 7.2.5.3. Italy
      • 7.2.5.3.1. By Distribution Channel
        • 7.2.5.3.1.1. Supermarkets and Hypermarkets
        • 7.2.5.3.1.2. Pharmacies
        • 7.2.5.3.1.3. Online Retail
        • 7.2.5.3.1.4. Others
    • 7.2.5.4. U.K.
      • 7.2.5.4.1. By Distribution Channel
        • 7.2.5.4.1.1. Supermarkets and Hypermarkets
        • 7.2.5.4.1.2. Pharmacies
        • 7.2.5.4.1.3. Online Retail
        • 7.2.5.4.1.4. Others
    • 7.2.5.5. Spain
      • 7.2.5.5.1. By Distribution Channel
        • 7.2.5.5.1.1. Supermarkets and Hypermarkets
        • 7.2.5.5.1.2. Pharmacies
        • 7.2.5.5.1.3. Online Retail
        • 7.2.5.5.1.4. Others
    • 7.2.5.6. Rest of Europe
      • 7.2.5.6.1. By Distribution Channel
        • 7.2.5.6.1.1. Supermarkets and Hypermarkets
        • 7.2.5.6.1.2. Pharmacies
        • 7.2.5.6.1.3. Online Retail
        • 7.2.5.6.1.4. Others

8. Asia Pacific Botanical Supplements Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Size Estimates and Forecast
  • 8.2.1. By Source
    • 8.2.1.1. Spices
    • 8.2.1.2. Herbs
    • 8.2.1.3. Flowers
    • 8.2.1.4. Leaves
    • 8.2.1.5. Others
  • 8.2.2. By Form
    • 8.2.2.1. Powder
    • 8.2.2.2. Liquid
    • 8.2.2.3. Tablets
    • 8.2.2.4. Capsules
    • 8.2.2.5. Others
  • 8.2.3. By Functionality
    • 8.2.3.1. Energy & Weight Management
    • 8.2.3.2. General Health
    • 8.2.3.3. Bone & Joint Health
    • 8.2.3.4. Gastrointestinal Health
    • 8.2.3.5. Immunity
    • 8.2.3.6. Anti-Cancer
    • 8.2.3.7. Others
  • 8.2.4. By Distribution Channel
    • 8.2.4.1. Supermarkets and Hypermarkets
    • 8.2.4.2. Pharmacies
    • 8.2.4.3. Online Retail
    • 8.2.4.4. Others
  • 8.2.5. By Country (Value)
    • 8.2.5.1. China
      • 8.2.5.1.1. By Distribution Channel
        • 8.2.5.1.1.1. Supermarkets and Hypermarkets
        • 8.2.5.1.1.2. Pharmacies
        • 8.2.5.1.1.3. Online Retail
        • 8.2.5.1.1.4. Others
    • 8.2.5.2. India
      • 8.2.5.2.1. By Distribution Channel
        • 8.2.5.2.1.1. Supermarkets and Hypermarkets
        • 8.2.5.2.1.2. Pharmacies
        • 8.2.5.2.1.3. Online Retail
        • 8.2.5.2.1.4. Others
    • 8.2.5.3. Japan
      • 8.2.5.3.1. By Distribution Channel
        • 8.2.5.3.1.1. Supermarkets and Hypermarkets
        • 8.2.5.3.1.2. Pharmacies
        • 8.2.5.3.1.3. Online Retail
        • 8.2.5.3.1.4. Others
    • 8.2.5.4. Australia
      • 8.2.5.4.1. By Distribution Channel
        • 8.2.5.4.1.1. Supermarkets and Hypermarkets
        • 8.2.5.4.1.2. Pharmacies
        • 8.2.5.4.1.3. Online Retail
        • 8.2.5.4.1.4. Others
    • 8.2.5.5. Rest of Asia Pacific
      • 8.2.5.5.1. By Distribution Channel
        • 8.2.5.5.1.1. Supermarkets and Hypermarkets
        • 8.2.5.5.1.2. Pharmacies
        • 8.2.5.5.1.3. Online Retail
        • 8.2.5.5.1.4. Others

9. South America Botanical Supplements Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Size Estimates and Forecast
  • 9.2.1. By Source
    • 9.2.1.1. Spices
    • 9.2.1.2. Herbs
    • 9.2.1.3. Flowers
    • 9.2.1.4. Leaves
    • 9.2.1.5. Others
  • 9.2.2. By Form
    • 9.2.2.1. Powder
    • 9.2.2.2. Liquid
    • 9.2.2.3. Tablets
    • 9.2.2.4. Capsules
    • 9.2.2.5. Others
  • 9.2.3. By Functionality
    • 9.2.3.1. Energy & Weight Management
    • 9.2.3.2. General Health
    • 9.2.3.3. Bone & Joint Health
    • 9.2.3.4. Gastrointestinal Health
    • 9.2.3.5. Immunity
    • 9.2.3.6. Anti-Cancer
    • 9.2.3.7. Others
  • 9.2.4. By Distribution Channel
    • 9.2.4.1. Supermarkets and Hypermarkets
    • 9.2.4.2. Pharmacies
    • 9.2.4.3. Online Retail
    • 9.2.4.4. Others
  • 9.2.5. By Country (Value)
    • 9.2.5.1. Brazil
      • 9.2.5.1.1. By Distribution Channel
        • 9.2.5.1.1.1. Supermarkets and Hypermarkets
        • 9.2.5.1.1.2. Pharmacies
        • 9.2.5.1.1.3. Online Retail
        • 9.2.5.1.1.4. Others
    • 9.2.5.2. Argentina
      • 9.2.5.2.1. By Distribution Channel
        • 9.2.5.2.1.1. Supermarkets and Hypermarkets
        • 9.2.5.2.1.2. Pharmacies
        • 9.2.5.2.1.3. Online Retail
        • 9.2.5.2.1.4. Others
    • 9.2.5.3. Rest of South America
      • 9.2.5.3.1. By Distribution Channel
        • 9.2.5.3.1.1. Supermarkets and Hypermarkets
        • 9.2.5.3.1.2. Pharmacies
        • 9.2.5.3.1.3. Online Retail
        • 9.2.5.3.1.4. Others

10. Middle East & Africa Botanical Supplements Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Size Estimates and Forecast
  • 10.2.1. By Source
    • 10.2.1.1. Spices
    • 10.2.1.2. Herbs
    • 10.2.1.3. Flowers
    • 10.2.1.4. Leaves
    • 10.2.1.5. Others
  • 10.2.2. By Form
    • 10.2.2.1. Powder
    • 10.2.2.2. Liquid
    • 10.2.2.3. Tablets
    • 10.2.2.4. Capsules
    • 10.2.2.5. Others
  • 10.2.3. By Functionality
    • 10.2.3.1. Energy & Weight Management
    • 10.2.3.2. General Health
    • 10.2.3.3. Bone & Joint Health
    • 10.2.3.4. Gastrointestinal Health
    • 10.2.3.5. Immunity
    • 10.2.3.6. Anti-Cancer
    • 10.2.3.7. Others
  • 10.2.4. By Distribution Channel
    • 10.2.4.1. Supermarkets and Hypermarkets
    • 10.2.4.2. Pharmacies
    • 10.2.4.3. Online Retail
    • 10.2.4.4. Others
  • 10.2.5. By Country (Value)
    • 10.2.5.1. South Africa
      • 10.2.5.1.1. By Distribution Channel
        • 10.2.5.1.1.1. Supermarkets and Hypermarkets
        • 10.2.5.1.1.2. Pharmacies
        • 10.2.5.1.1.3. Online Retail
        • 10.2.5.1.1.4. Others
    • 10.2.5.2. UAE
      • 10.2.5.2.1. By Distribution Channel
        • 10.2.5.2.1.1. Supermarkets and Hypermarkets
        • 10.2.5.2.1.2. Pharmacies
        • 10.2.5.2.1.3. Online Retail
        • 10.2.5.2.1.4. Others
    • 10.2.5.3. Rest of Middle East & Africa
      • 10.2.5.3.1. By Distribution Channel
        • 10.2.5.3.1.1. Supermarkets and Hypermarkets
        • 10.2.5.3.1.2. Pharmacies
        • 10.2.5.3.1.3. Online Retail
        • 10.2.5.3.1.4. Others

11. Competitive Matrix

• 11.1. Business Strategies Adopted by Leading Players
• 11.2. Global Botanical Supplements Market Revenue Share/Ranking Analysis, By Key Manufacturer

12. Company Profiles

• 12.1. Dabur India
  • 12.1.1. Overview
  • 12.1.2. Description
  • 12.1.3. Product Portfolio
  • 12.1.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.1.5. Recent Developments
• 12.2. NBTY Inc.
  • 12.2.1. Overview
  • 12.2.2. Description
  • 12.2.3. Product Portfolio
  • 12.2.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.2.5. Recent Developments
• 12.3. Ricola AG
  • 12.3.1. Overview
  • 12.3.2. Description
  • 12.3.3. Product Portfolio
  • 12.3.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.3.5. Recent Developments
• 12.4. Procter and Gamble
  • 12.4.1. Overview
  • 12.4.2. Description
  • 12.4.3. Product Portfolio
  • 12.4.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.4.5. Recent Developments
• 12.5. Nutraceutical International Company
  • 12.5.1. Overview
  • 12.5.2. Description
  • 12.5.3. Product Portfolio
  • 12.5.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.5.5. Recent Developments
• 12.6. BASF SE
  • 12.6.1. Overview
  • 12.6.2. Description
  • 12.6.3. Product Portfolio
  • 12.6.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.6.5. Recent Developments
• 12.7. The Himalaya Drug Company
  • 12.7.1. Overview
  • 12.7.2. Description
  • 12.7.3. Product Portfolio
  • 12.7.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.7.5. Recent Developments
• 12.8. Glanbia Nutritionals
  • 12.8.1. Overview
  • 12.8.2. Description
  • 12.8.3. Product Portfolio
  • 12.8.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.8.5. Recent Developments
• 12.9. Botanicalife International of America, Inc.
  • 12.9.1. Overview
  • 12.9.2. Description
  • 12.9.3. Product Portfolio
  • 12.9.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.9.5. Recent Developments
• 12.10. Prorganiq
  • 12.10.1. Overview
  • 12.10.2. Description
  • 12.10.3. Product Portfolio
  • 12.10.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.10.5. Recent Developments